Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adipose-derived stromal cell therapy for diabetic foot ulcer
IRCT20080901001159N26Phase 2Completed
- Sponsor
- Skin and Stem Cell Research Center
- Start
- Jul 2019
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of adipose derived mesenchymal stromal cells in diabetic foot ulcer (DFU) (3 arms), sponsored by Skin and Stem Cell Research Center. Primary endpoints: Safety, Wound size and 2 more. Started Jul 2019; status: completed.
02
Drugs
adipose derived mesenchymal stromal cells
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on IRCT20080901001159N26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20080901001159N26.